Why get tested?

The test, together with the measurement of the nuchal translucency (NT) and the clinical-anamnestic data of the pregnant woman, allows to evaluate the risk of a fetus presenting chromosomal abnormalities.
The test is suitable for all pregnant women and, in particular, for women over the age of 35 who have an increased risk of having a fetus affected by trisomy 21, 13 or 18.

What the test detects

The test quantifies PAPP-A and free-beta-hCG proteins.

What variants cause

The test identifies an increased risk of a fetus having chromosomal abnormalities.

How testing works

The test is performed on a maternal venous blood sample for the quantification of PAPP-A and free-beta-hCG proteins.

Reporting time

Results in 2-3 working days.

Sensitivity and specificity

Diagnostic sensibility for trisomy 21 is 90%.

Fill out the form for further information

    * You are a